Invention Grant
- Patent Title: Amide compounds as kinase inhibitors, compositions and methods of treatment
-
Application No.: US16393868Application Date: 2019-04-24
-
Publication No.: US10738007B2Publication Date: 2020-08-11
- Inventor: Tong Wang , Stephen Gately
- Applicant: TRANSLATIONAL DRUG DEVELOPMENT, LLC
- Applicant Address: US AZ Scottsdale
- Assignee: Translation Drug Development, LLC
- Current Assignee: Translation Drug Development, LLC
- Current Assignee Address: US AZ Scottsdale
- Agency: Booth Udall Fuller, PLC
- Agent Rodney J. Fuller
- Main IPC: C07D213/04
- IPC: C07D213/04 ; C07D487/04
Abstract:
The present disclosure relates to certain amides and heterocyclic compounds. The present disclosure also relates to uses of these compounds to inhibit Rho-associated protein kinases and treat diseases including autoimmune disorders, graft versus host disease (GVHD), inflammation, cardiovascular disorders, central nervous system disorders, and neoplastic disorders.
Public/Granted literature
- US20190248744A1 AMIDE COMPOUNDS AS KINASE INHIBITORS, COMPOSITIONS AND METHODS OF TREATMENT Public/Granted day:2019-08-15
Information query
